Cadre (CDRE) Competitors $33.95 -1.80 (-5.03%) (As of 12/20/2024 04:32 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CDRE vs. ENOV, ESTA, AVNS, SMTI, INGN, LAKE, ZJYL, RBOT, MLSS, and APTShould you be buying Cadre stock or one of its competitors? The main competitors of Cadre include Enovis (ENOV), Establishment Labs (ESTA), Avanos Medical (AVNS), Sanara MedTech (SMTI), Inogen (INGN), Lakeland Industries (LAKE), Jin Medical International (ZJYL), Vicarious Surgical (RBOT), Milestone Scientific (MLSS), and Alpha Pro Tech (APT). These companies are all part of the "surgical appliances & supplies" industry. Cadre vs. Enovis Establishment Labs Avanos Medical Sanara MedTech Inogen Lakeland Industries Jin Medical International Vicarious Surgical Milestone Scientific Alpha Pro Tech Cadre (NYSE:CDRE) and Enovis (NYSE:ENOV) are both industrial products companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation, risk and community ranking. Do institutionals & insiders hold more shares of CDRE or ENOV? 44.0% of Cadre shares are owned by institutional investors. Comparatively, 98.4% of Enovis shares are owned by institutional investors. 37.0% of Cadre shares are owned by insiders. Comparatively, 2.4% of Enovis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts prefer CDRE or ENOV? Cadre currently has a consensus target price of $39.75, suggesting a potential upside of 17.08%. Enovis has a consensus target price of $67.00, suggesting a potential upside of 55.38%. Given Enovis' stronger consensus rating and higher probable upside, analysts plainly believe Enovis is more favorable than Cadre.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cadre 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Enovis 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 Does the media prefer CDRE or ENOV? In the previous week, Cadre and Cadre both had 5 articles in the media. Enovis' average media sentiment score of 1.14 beat Cadre's score of 0.49 indicating that Enovis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cadre 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Enovis 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation and earnings, CDRE or ENOV? Cadre has higher earnings, but lower revenue than Enovis. Enovis is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCadre$516.16M2.67$38.64M$0.8340.90Enovis$2.00B1.20-$33.26M-$2.19-19.69 Which has more risk and volatility, CDRE or ENOV? Cadre has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500. Comparatively, Enovis has a beta of 1.94, indicating that its share price is 94% more volatile than the S&P 500. Is CDRE or ENOV more profitable? Cadre has a net margin of 6.34% compared to Enovis' net margin of -5.95%. Cadre's return on equity of 12.88% beat Enovis' return on equity.Company Net Margins Return on Equity Return on Assets Cadre6.34% 12.88% 6.06% Enovis -5.95%4.39%2.80% Does the MarketBeat Community believe in CDRE or ENOV? Enovis received 13 more outperform votes than Cadre when rated by MarketBeat users. Likewise, 61.70% of users gave Enovis an outperform vote while only 55.17% of users gave Cadre an outperform vote. CompanyUnderperformOutperformCadreOutperform Votes1655.17% Underperform Votes1344.83% EnovisOutperform Votes2961.70% Underperform Votes1838.30% SummaryEnovis beats Cadre on 9 of the 17 factors compared between the two stocks. Ad ProsperityPubCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem Get Cadre News Delivered to You Automatically Sign up to receive the latest news and ratings for CDRE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDRE vs. The Competition Export to ExcelMetricCadreSurgical appliances & supplies IndustryIndustrial SectorNYSE ExchangeMarket Cap$1.38B$9.53B$9.24B$19.19BDividend Yield0.98%1.38%2.09%3.61%P/E Ratio40.9019.5621.0841.30Price / Sales2.6732.804.8617.58Price / Cash23.3722.3719.2621.28Price / Book6.475.494.225.32Net Income$38.64M$182.72M$398.18M$989.88M7 Day Performance-3.77%-4.48%-4.86%-3.54%1 Month Performance3.54%-4.23%-2.10%-3.68%1 Year Performance6.16%-12.17%14.80%12.14% Cadre Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDRECadre3.0752 of 5 stars$33.95-5.0%$39.75+17.1%+6.6%$1.38B$516.16M40.902,435Gap DownHigh Trading VolumeENOVEnovis2.9783 of 5 stars$45.99-0.3%$67.00+45.7%-21.5%$2.57B$2.00B-21.396,550Positive NewsESTAEstablishment Labs2.5211 of 5 stars$46.53+1.2%$60.60+30.2%+73.3%$1.30B$153.07M-18.03960Positive NewsAVNSAvanos Medical3.4859 of 5 stars$17.83-0.8%N/A-27.4%$819.47M$673.30M52.443,771SMTISanara MedTech1.9969 of 5 stars$33.73-2.7%$44.00+30.4%-14.5%$294.80M$64.99M-35.0060INGNInogen2.5642 of 5 stars$8.86-1.1%$7.00-21.0%+46.0%$211.03M$331.52M-3.98834Analyst DowngradeNews CoverageLAKELakeland Industries4.5837 of 5 stars$23.66+4.2%$26.50+12.0%+28.5%$175.23M$151.82M-252.221,750Analyst ForecastAnalyst RevisionZJYLJin Medical InternationalN/A$0.78+0.3%N/A-99.0%$120.92M$19.82M0.00245Gap DownRBOTVicarious Surgical1.2864 of 5 stars$14.40+1.4%$10.25-28.8%-5.0%$85.08MN/A-1.383MLSSMilestone Scientific2.1612 of 5 stars$0.83+2.4%$1.25+50.7%+54.0%$64.61M$8.88M-11.5730Analyst ForecastNews CoverageAPTAlpha Pro TechN/A$5.22-0.6%N/A+3.1%$57.42M$59.29M14.19120 Related Companies and Tools Related Companies ENOV Alternatives ESTA Alternatives AVNS Alternatives SMTI Alternatives INGN Alternatives LAKE Alternatives ZJYL Alternatives RBOT Alternatives MLSS Alternatives APT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CDRE) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadre Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cadre With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CDRE Stock Alerts